Aveo Pharmaceuticals, Inc.
AVEODelisted Jan 19, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001325879
Aveo Pharmaceuticals, Inc. was delisted on Jan 19, 2023; its insiders filed their last Form 4 on Jan 19, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $367.6M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Aveo Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 55 | 77 | +22 |
| Shares | 15.4M | 16.4M | +1.03M (+6.7%) |
| Value | $101.2M | $135.3M | +$34.1M (+33.8%) |
New holders (27)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (5)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Group One Trading, L.P. | 7,706 | $51.0K |
| Steward Financial Group LLC | 2,000 | $13.0K |
| Larson Financial Group LLC | 566 | $4.00K |
| National Bank of Canada | 100 | $1.00K |
| Blue Bell Private Wealth Management, LLC | 20 | $0 |